1 Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
2 Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401–9.
4 Robert J. Stachler et al. Clinical Practice Guideline: Sudden Hearing Loss. Otolaryngology – Head and Neck Surgery. 2012;146:1.
5 Pezzoli M, Magnano M, Maffi L, Pezzoli L, Marcato P, Orione M, Cupi D, Bongioannini G. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study. Eur Arch Otorhinolaryngol. 2015;272(7):1659–66.
6 Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol. 2013;34(6):1021–6.
7 Hosokawa S, Sugiyama KI, Takahashi G, Hashimoto YI, Hosokawa K, Takebayashi S, Mineta H. Hyperbaric Oxygen Therapy as Adjuvant Treatment for Idiopathic Sudden Sensorineural Hearing Loss after Failure of Systemic Steroids. Audiol Neurootol. 2017;22(1):9–14.
8 Carlsson P-I, Hall M, Lind K-J, Danermark B. Quality of life, psychosocial consequences, and audiological rehabilitation after sudden sensorineural hearing loss. International Journal of Audiology. 2011;50:139–44.
9 Ramesh Nosrati-Zarenoe, Stig Arlinger & Elisabeth Hultcrantz. Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database. Acta Oto-Laryngologica. 2007;127:1168–75.
10 Hu Q, Liang X, Chen D, Chen Y, Doycheva D, Tang J, Tang J, Zhang JH. Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats. Stroke. 2014;45(6):1807–14.
11 Grimberg-Peters D, Büren C, Windolf J, Wahlers T, Paunel-Görgülü A. Hyperbaric Oxygen Reduces Production of Reactive Oxygen Species in Neutrophils from Polytraumatized Patients Yielding in the Inhibition of p38 MAP Kinase and Downstream Pathways. PLoS One. 2016;11(8).
12 Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71(2):119–24.
13 Jokinen-Gordon H, Barry RC, Watson B, Covington DS. A Retrospective Analysis of Adverse Events in Hyperbaric Oxygen Therapy (2012–2015): Lessons Learned From 1,5 Million Treatments. Adv Skin Wound Care. 2017;30(3):125–129.